Aqueous-based peptide synthesis The solid-phase synthesis process described above has dominated peptide manufacturing for decades, but as weve seen, it comes with significant challenges
The Novel GLP-1/GIP Analogue DA5-CH Reduces Tau Phosphorylation and Normalizes Theta Rhythm in the Icv
Safety and Compliance Research Use Only GHK-Cu 50mg Copper Peptide is not approved for human consumption or therapeutic use
We see many individuals who are so focused on the needle that they forget the basic steps of the process
(7)Fmoc-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val- (7) Preparation of Fmoc-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-resin: (6)Fmoc-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-1050530105010603DMF3DMF2DMFFmoc-Ala-OHDIEATBTU/HOBtHBTU/HOBtBOP/HOBt105010603DMF3DMF2Fmoc-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val- In the Fmoc-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-resin in step (6), add the decapping reagent at 10-50C for 5-30 minutes, dry it with a vacuum pump, and re-add the decapping reagent React the reagent at 10-50C for 10-60 minutes, drain it, wash it with isopropanol for 3 times, DMF for 3 times, and distilled DMF for 2 times, add Fmoc-Ala-OH, DIEA, TBTU dissolved in DMF /HOBt or HBTU/HOBt or BOP/HOBt mixture, react at 10-50C for 10-60 minutes, dry with a vacuum pump, wash 3 times with isopropanol, 3 times with DMF, 2 times with re-distilled DMF, Drain, obtain Fmoc-Ala-Asp(otBu)-Asp(otBu)-Ala-Gly-Leu-Val-resin
